Pharmafile Logo
Pharmafocus logo
Advanced Search

Exscientia enter first-ever AI cancer drug into Phase I trials

April 9, 2021
Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news

Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …

News
moderna_norwood_plant

Moderna publishes antibody persistence data of COVID-19 vaccine

April 9, 2021
Medical Communications

Moderna have published antibody persistence data out to six months following the second dose of its COVID-19 vaccine (mRNA-1273) in …

News
lilly_entrance_web

Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint

April 9, 2021
Medical Communications COVID-19, Eli Lily

Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did …

News
abbottweb

Abbott receives CE mark approval for TriClip device

April 9, 2021
Medical Communications

Abbott have received CE Mark approval for its next-generation TriClip Transcatheter Tricuspid Valve Repair System, the first-of-its-kind tricuspid heart valve …

News

Novartis MS therapy gains MHRA and EC approval

April 8, 2021
European Commission, MHRA, Novartis, pharma, pharma news

The MHRA and European Commission have both granted marketing authorisation to Novartis for its Kesimpta therapy, for the treatment of …

News
Gilead sign

FDA approve Gilead’s breast cancer treatment after Phase III trial

April 8, 2021
FDA, Gilead, Trodelvy, pharma, pharma news

The FDA has approved Gilead’s Trodelvy therapy for the treatment of metastatic triple-negative breast cancer (TNBC).

News
img_4190-e1376666350337-web

MHRA recommends AstraZeneca jab not be offered to under 30s

April 8, 2021

The MHRA have recommended that people under the age of 30 not be offered the AstraZeneca COVID-19 vaccine, due to …

News

GBT publish successful results from sickle cell disease study

April 8, 2021

Global Blood Therapeutics (GBT) have published the successful results from their Phase III study of Oxbryta (voxelotor) tablets in patients …

News

Collaboration announced to investigate COVID brain fog treatment

April 8, 2021

Akili Interactive has announced a collaboration with Weill Cornell Medicine, New York-Presbyterian Hospital and Vanderbilt University Medical Center, to evaluate …

News

Intravac appoints Nathalie Laarakker as CFO

April 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team. …

Appointment

Smithers promotes Nikki Lucas to Principal Project Manager

April 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nikki Lucas has been appointed Principal Project Manager within Smithers’ Medical Device Physical Testing team. Lucas has over a decade …

Appointment

New CEO appointed at Nordic Nanovector

April 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector have appointed Peter Braun as their new Chief Executive Officer. Braun is an experienced and entrepreneurial pharmaceutical leader, …

Appointment
chas_taylor

Ceryx Medical announce new chairman Chas Taylor

April 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman. The appointment comes at an interesting time …

Appointment
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 7, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen plenty of COVID-19 vaccine news; AstraZeneca has halted the paediatric trial of their jab amid …

News
Moderna building

UK begins rollout of Moderna COVID-19 vaccine

April 7, 2021
Research and Development COVID-19, COVID-19 vaccine, Moderna, Moderna vaccine, pharma, pharma news

The first Moderna COVID-19 vaccine in the UK has today been administered, beginning the rollout of the country’s third vaccine …

News

Novartis and Artios Pharma to collaborate on DDR cancer therapies

April 7, 2021
Research and Development Novartis, RLT, oncology

Novartis and Artios Pharma have announced a global research collaboration to discover and validate next generation DNA damage response (DDR) …

News
astrazeneca_sign_sky

AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe

April 7, 2021
Research and Development AstraZeneca, COVID-19, Vaccine

AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a …

News

NICE recommends CBT, acupuncture, and anti-depressants for chronic pain

April 7, 2021
Research and Development NICE, antidepressant, chronic pain

A new NICE guideline on the assessment and management of chronic primary pain does not recommend the prescription of painkillers, …

News

Valneva’s inactivated COVID-19 vaccine candidate advances to Phase III trial

April 6, 2021
Manufacturing and Production COVID-19, COVID-19 vaccine, Valneva, Valneva vaccine, inactivated vaccine

Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate …

News
Janssen sign

Janssen agrees $780 million deal for authorisation of Cidara flu treatment

April 6, 2021
Manufacturing and Production Janssen, cidara, influenza

Janssen has struck a deal worth up to $780 million with Cidara Therapeutics for exclusive worldwide rights to Cidara’s CD388 …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026